References
- Beaudet MP, Tully P, St-Arnaud J. Life expectancy. Health Rep.17(1), 43–47 (2005).
- Statistics Canada. Life Expectancy, Abridged Life Table, at Birth and at Age 65, by Sex, Canada, Provinces and Territories, Annual (Years) (CANSIM Table 102-0511). Statistics Canada, Ottawa, Canada (2008).
- Cutler D, Deaton A, Lleras-Muney A. The determinants of mortality. J. Econ. Persp.3, 97–120 (2006).
- Welsfeldt ML, Sleman SJ. Advances in the prevention and treatment of cardiovascular disease. Health Affairs26(1), 25–37 (2007).
- Lichtenberg FR. The effect of new drug approvals on HIV mortality in the US, 1987–1998. Econ. Hum. Biol.1(2), 259–266 (2003).
- Lichtenberg FR. Sources of U.S. longevity increase, 1960–2001. Q. Rev. Econ. Finance44, 369–389 (2004).
- Crémieux PY, Meilleur MC, Ouellette P et al. Public and private pharmaceutical spending as determinants of health outcomes in Canada. Health Econ.14(2), 107–116 (2005).
- Crémieux PY, Meilleur MC, Ouellette P et al. Erratum: public and private pharmaceutical spending as determinants of health outcomes in Canada. Health Economics14(2), 107–116 (2005).
- Frech HE, Miller RD. The effects of pharmaceutical consumption and obesity on the quality of life in the OECD countries. Pharmacoeconomics22(2, Suppl. 2), 25–36 (2004).
- Shaw JW, Horrace WC, Vogel RJ. The determinants of life expectancy: an analysis of the OECD health data. South. Econ. J.71(4), 768–783 (2005).
- Viscusi WK, Aldy JE. The value of a statistical life: a critical review of market estimates throughout the world. J. Risk Uncertain.27(1), 5–76 (2003).
- Babazono A, Hillman AL. A comparison of international health outcomes and health care spending. Int. J. Technol. Assess. Health Care10, 376–381 (1994).
- Liu L, Cline RR, Schondelmeyer SW, Schommer JC. Pharmaceutical expenditures as a correlate of population health in industrialized nations. Ann. Pharmacother.42(3), 368–374 (2008).
- Morgan S. Price and Productivity Measurement in a Pharmaceutical Sector Sub-market: the Real Cost of Treating Hypertension. Working Paper. University of British Columbia Centre for Health Services and Policy Research, BC, Canada (2001).
- Gerdtham UG, Jonsson B. International comparisons of health expenditure: theory, data and econometric analysis. In: Handbook of Health Economics (Vol. 1A). Culyer AJ, Newhouse JP (Eds). Elsevier Science, Amsterdam, The Netherlands (2000).
- Fuchs VR, Sox HC. Physicians’ views of the relative importance of thirty medical innovations. Health Affairs20(5), 30–42 (2001).
- Akkoyunlu S, Lichtenberg FR, Siliverstovs B et al.Spurious Correlation in Estimation of the Health Production Function: a Note. Working Paper No. 0903. University of Zurich, Socioeconomic Institute, Zurich, Switzerland (2009).
- Granger CWJ. Empirical Modelling in Economics. Cambridge University Press, Cambridge, UK (1999).
- Neumann PJ, Sandberg EA, Bell CM, Stone PW, Chapman RH. Are pharmaceuticals cost-effective?. A review of the evidence. Health Affairs19(2), 92–109 (2000).
- Gravelle H, Backhouse M. International cross-section analysis of the determination of mortality. Soc. Sci. Med.25(5), 427–441 (1987).
- Nixon J, Ulmann P. The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link. Eur. J. Health Econ.7(1), 7–18 (2006).
- Guindon GE, Contoyannis P. A second look at pharmaceutical spending as determinants of health outcomes in Canada. Health Economics DOI: 10.1002/hec.1415 (2008).
- Martin S, Rice N, Smith PC. Does health care spending improve health outcomes?. Evidence from English programme budgeting data. J. Health Econ.27(4), 826–842 (2008).
- Lichtenberg FR. Have newer cardiovascular drugs reduced hospitalization?. Evidence from longitudinal country-level data on 20 OECD countries, 1995–2003. Health Econ.18(5), 519–534 (2008).
Websites
- Hollis A, Pogge T. The Health Impact Fund: Making New Medicines Accessible to All. Incentives for Global Health, Yale University, CT, USA (2008). www.yale.edu/macmillan/igh/hif_book.pdf
- Canadian Institute for Health Information, National Health Expenditures Trends http://secure.cihi.ca/cihiweb/products/national_health_expenditure_trends_1975_2006_e.pdf
- Statistics Canada, E-Stat http://estat.statcan.ca/cgi-win/CNSMCGI.EXE?LANG=E&CIITables=2966&ResultTemplate=ESTAT\CII_FLST&ROOTDIR=ESTAT/&LangFldr=English/&C2DB=
- OECD Health Data 2007 www.sourceoecd.org/vl=2159454/cl=16/nw=1/rpsv/ij/oecdstats/99991012/v1n1/s1/p1
- Centers for Disease Control and Prevention, National Center for Health Statistics www.cdc.gov/nchs/data/hus/hus06.pdf#027
- US Food and Drug Administration, Center for Drug Evaluation and Research, New Molecular Entity (NME) Drug and New Biologic Approvals www.fda.gov/cder/rdmt/default.htm
- Centers for Medicare & Medicaid Services, Office of the Actuary, National Health Statistics Group, National health accounts www.cms.hhs.gov/NationalHealthExpendData/02_NationalHealthAccountsHistorical.asp#TopOfPage